Asia-Pacific In Vitro Diagnostics Market Outlook to 2016

Asia-Pacific In Vitro Diagnostics Market Outlook to 2016

Summary

GlobalData’s new report, “Asia Pacific In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Asia Pacific In Vitro Diagnostics market - Japan, China, India, and Australia. The report provides value (USD million) data for all the market categories - Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture, and Haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Countries covered include Japan, China, India, and Australia.
• Market size and company share data for In Vitro Diagnostics market categories - Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture, and Haematology.
• Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the market categories and countries.
• Global corporate-level profiles of key companies operating within the Asia Pacific In Vitro Diagnostics market.
• Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, Biomerieux Sa, Beckman Coulter, Bio-Rad Laboratories, Ortho-Clinical Diagnostics, Becton, Dickinson and Company, Sysmex Corporation, Phadia, Qiagen, and Alere.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Asia Pacific In Vitro Diagnostics competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.